A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: A machine-learning prognostic score derived from the phase III MCL0208 trial stratified mantle-cell-lymphoma patient outcomes and was checked in external trial cohorts.
Technology: Methods define trial and prognostic model; Results report score stratification and external validation in European MCL cohorts.
Publication: Peer-reviewed paper · Test context: prospective or independent check. Catalog categories, not an evidence grade.
- AI contribution
- Methods define trial and prognostic model; Results report score stratification and external validation in European MCL cohorts.
- Limitation / still unknown
- The score was derived from the MCL0208 trial and checked in external trial cohorts; this is prognostic stratification evidence, not proof of treatment benefit.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC8750124/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 4/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.